Market Snapshot

BSE Sensex: 84929.36 0.53%
BSE 500: 37143.96 0.79%
BSE 200: 11726.66 0.72%
BSE 100: 27175.1 0.62%
BSE MidCap: 46547.3 1.26%
BSE SmallCap: 50800.77 1.25%
BSE BANKEX: 66140.65 0.25%
BSE IT: 37448.32 0.50%
Nifty 50: 25966.4 0.58%
Nifty 500: 23677.55 0.79%
Nifty 200: 14436.1 0.73%
Nifty 100: 26488 0.62%
Nifty Midcap 100: 60310.15 1.20%
Nifty Small 100: 17390.35 1.34%
Nifty IT: 38691.6 0.15%
Nifty PSU Bank: 8357.3 0.38%

News:

Aarti Inds gains after securin...
Shriram Finance hits record hi...
Ola Electric rallies after pro...
Shree Renuka Sugars Ltd leads ...
Shish Industries Ltd leads los...

Fermenta Biotech Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

19 Dec 2025 | 03:59 PM

353.50

3.60 (1.03%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-8.9%

Return (1Y)

Underperformed BSE Healthcare by 7.2%
More Volatile

3.48%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.52%
Consistent Performer

7/12

Months

beaten BSE Healthcare
AxisDirect View

No View

52 Week High-Low

449

219

News & Announcements

Fermenta Biotech announces board meeting date
11 days ago

Fermenta Biotech announces board meeting date

08 - Dec - 2025 12:00 | 11 days ago

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 10 December 2025.
Powered by Capital Market - Live News
Fermenta Biotech consolidated net profit rises 65.91% in the September 2025 quarter
37 days ago

Fermenta Biotech consolidated net profit rises 65.91% in the September 2025 quarter

12 - Nov - 2025 12:00 | 37 days ago

Net profit of Fermenta Biotech rose 65.91% to Rs 18.88 crore in the quarter ended September 2025 as against Rs 11.38 crore during the previous quarter ended September 2024. Sales rose 37.03% to Rs 130.22 crore in the quarter ended September 2025 as against Rs 95.03 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 130.22 95.03 37

OPM % 20.46 19.76 -

PBDT 29.49 17.97 64

PBT 24.08 11.82 104

NP 18.88 11.38 66

Powered by Capital Market - Live News
Fermenta Biotech schedules board meeting
50 days ago

Fermenta Biotech schedules board meeting

30 - Oct - 2025 12:00 | 50 days ago

Fermenta Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2025.
Powered by Capital Market - Live News
Fermenta Biotech receives Indian patent for its plant-based Vitamin D3
98 days ago

Fermenta Biotech receives Indian patent for its plant-based Vitamin D3

12 - Sep - 2025 12:00 | 98 days ago

Fermenta Biotech announced that the Indian Patent Office has formally granted a patent for its invention of a plant-based Vitamin D3.

Fermenta's newly granted patent safeguards its proprietary process for producing plant based Vitamin D3, marking a significant advancement in its innovation pipeline and reinforcing its leadership in the global Vitamin D3 domain. This market-leading vegan solution responds to the accelerating global demand for ethically sourced, sustainable nutrition and positions Fermenta at the forefront of the plant-based nutrition revolution. By enabling the production of completely vegan and vegetarian-friendly Vitamin D3, the invention captures emerging opportunities across nutraceutical and food fortification sectors, where sustainable, plant-derived ingredients command premiums and growing market share.

Prashant Nagre, Managing Director of Fermenta, said: ?The grant of this patent is a proud milestone in our journey of innovation. It reflects our dedication to addressing evolving consumer needs with environmentally conscious solutions. Plant-based Vitamin D3 represents the future of nutrition, and this patent reinforces our ability to deliver differentiated offerings that create long-lasting impact for both our partners and society at large. It also strengthens India's role as a hub for pioneering industrial innovation, showcasing how local science can contribute to global wellness.?
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in DIL Ltd has decreased by -51.37% since past 1 Year
Promoter shareholding in DIL Ltd has increased by 3.26% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	130.22	95.03	37
OPM %	20.46	19.76	-
PBDT	29.49	17.97	64
PBT	24.08	11.82	104
NP	18.88	11.38	66

General Notifications

My Notifications

Research Notifications

Fermenta Biotech Ltd Share Price – BSE Pharmaceuticals, Small Cap

353.50 3.60 (1.03%)

News & Announcements

Price vs Volume

Stock Trivia

Fermenta Biotech Ltd Share Price – BSE
Pharmaceuticals, Small Cap

353.50

3.60 (1.03%)